Joseph Demille

Joseph DeMille is an accomplished financial professional with extensive experience in cost accounting and financial analysis. Currently serving as a Cost Accounting Manager at both Dexcom since April 2023 and Sorrento Therapeutics, Inc. since April 2021, Joseph previously worked at Qualcomm from March 2006 to February 2021 as a Principal (Staff) Financial Analyst/Principal (Staff) Cost Accountant. Joseph holds a Bachelor of Business Administration with an Emphasis in Accountancy from San Diego State University, earned between 1996 and 2001.